Kalytera on SPi NewsFollow our SPi News RSS Feed for kalytera

Featured kalytera News

[29 Jul 2019] Kalytera Announces Results of Shareholder Meeting Votes

[26 Jul 2019] Kalytera Will Not Proceed with Vote on Potential Share Consolidation

[16 Jul 2019] Kalytera Announces Completion of Food Effect and QTc Study

[05 Jul 2019] Kalytera to Hold Annual and Special Meeting on July 29, 2019

[27 Jun 2019] Kalytera to Acquire CBD Extraction Business

[25 Jun 2019] Kalytera Provides Update on GVHD Program

[21 Jun 2019] Kalytera Announces Grant of Stock Options to Directors

[21 Jun 2019] Kalytera Announces Changes to Board of Directors

[31 May 2019] Kalytera Reports First Quarter 2019 Financial Results

[28 May 2019] Kalytera Announces Data Further Elucidating CBD’s Mechanisms of Action in Prevention of GVHD

[14 May 2019] Kalytera Therapeutics, Inc. Announces Second Closing of Public Offering

[01 May 2019] Kalytera Reports 2018 Financial Results

[26 Apr 2019] Kalytera Therapeutics, Inc. Announces Closing of Public Offering

[17 Apr 2019] Kalytera Therapeutics Announces Filing of Short Form Prospectus

[07 Mar 2019] Kalytera Announces Closing of Private Placement of Convertible Debenture Units

[05 Mar 2019] Kalytera Announces Private Placement of Convertible Debenture Units

[09 Feb 2019] Kalytera Completes Deferral Transaction with Former Shareholders of Talent Biotechs

[05 Feb 2019] Kalytera Reports Additional Positive Data for CBD in Prevention of Acute GVHD

[28 Jan 2019] Kalytera Announces Grant of Stock Options to Certain Directors and Employees

[15 Jan 2019] Kalytera Announces Initiation of Research Coverage by Echelon Wealth Partners

[30 Nov 2018] Kalytera Reports Third Quarter 2018 Financial Results

[28 Sep 2018] Kalytera Announces Next Share Issuance under Payments Agreements with Salzman Group

[25 Sep 2018] Kalytera Announces Grant of Stock Options to Directors and Employees

[20 Sep 2018] Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD

[13 Sep 2018] Kalytera Confirms No Material Change in Operations

[30 Aug 2018] Kalytera Reports Second Quarter 2018 Financial Results

[24 Aug 2018] Kalytera Provides Update on Arrangement with Former Shareholders of Talent Biotechs

[16 Aug 2018] Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option

[02 Aug 2018] Kalytera Completes Pre-IND Meeting with FDA

[27 Jul 2018] Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting

[20 Jul 2018] Kalytera and Former Shareholders of Talent Biotechs Agree to Deferment of Milestone Payments

[10 Jul 2018] Kalytera Therapeutics Announces Short Form Prospectus Offering of Units

[05 Jul 2018] Kalytera Announces Pre-IND Meeting Date with FDA

[21 Jun 2018] Kalytera Provides Update on its Lead Program in Prevention and Treatment of GVHD

[15 Jun 2018] Kalytera Announces Second Payments Agreement with The Salzman Group of Israel

[30 May 2018] Kalytera Reports First Quarter 2018 Financial Results

[26 Apr 2018] Kalytera Issues CEO Letter to Shareholders

[20 Apr 2018] Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group

[22 Mar 2018] Kalytera Announces Next Issuance of Shares under Services Agreement with Salzman Group

[23 Feb 2018] Kalytera Announces Further Issuance of Shares under Services Agreement with Salzman Group

[31 Jan 2018] Kalytera Announces Grant of Stock Options

[26 Jan 2018] Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel

[12 Jan 2018] Kalytera Announces Settlement of Debt Transaction

[20 Dec 2017] Kalytera Therapeutics, Inc. Announces Closing of Brokered Private Placement

[05 Dec 2017] Kalytera Confirms No Material Change in Operations

[22 Nov 2017] Kalytera Announces $5 Million Private Placement of Convertible Debenture Units

[31 May 2017] Kalytera Reports First Quarter 2017 Financial Results

[02 May 2017] Kalytera Reports FY 2016 Results; Provides Corporate Update and 2017 Outlook

[17 Apr 2017] Kalytera Applies for $5 Million R&D Grant from IIA

[16 Feb 2017] Kalytera Therapeutics Completes Acquisition of Talent Biotechs


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us